Investigational Oral Medication Promising for Endometriosis Pain
Investigational oral agent, elagolix, shows promise for the treatment of endometriosis-related pain with good efficacy and safety data now out to 12 months in 2 extension studies; drug is awaiting approval. Medscape Medical News …read more